LOU, C., YOKOYAMA, S., ABDELHAMED, S., SAIKI, I., & HAYAKAWA, Y. (2016). Targeting the ataxia telangiectasia mutated pathway for effective therapy against hirsutine-resistant breast cancer cells. Oncology Letters, 12(1), 295. https://doi.org/10.3892/ol.2016.4554
Chicago Style (17th ed.) CitationLOU, CHENGHUA, SATORU YOKOYAMA, SHERIF ABDELHAMED, IKUO SAIKI, and YOSHIHIRO HAYAKAWA. "Targeting the Ataxia Telangiectasia Mutated Pathway for Effective Therapy Against Hirsutine-resistant Breast Cancer Cells." Oncology Letters 12, no. 1 (2016): 295. https://doi.org/10.3892/ol.2016.4554.
MLA (9th ed.) CitationLOU, CHENGHUA, et al. "Targeting the Ataxia Telangiectasia Mutated Pathway for Effective Therapy Against Hirsutine-resistant Breast Cancer Cells." Oncology Letters, vol. 12, no. 1, 2016, p. 295, https://doi.org/10.3892/ol.2016.4554.